Subscribe

Featured Content

    Top Trending Articles

    FDA Approvals, News & Updates

    Highlights from the Latest Issue: December 2023, Vol 14, No 6

    Value-Based Care

    Personalized Medicine | Browse By Specialty

    Hematologic Malignancies

    Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
    Phoebe Starr
    Chicago, IL—Interim results from the phase 3 COMMANDS trial demonstrated that first-line treatment with luspatercept-aamt (Reblozyl) increased hemoglobin levels and enabled nearly twice as many patients with transfusion-dependent, lower-risk myelodysplastic syndromes (MDS) to avoid red blood cell transfusions during the first 24 weeks of the study compared with standard-of-care epoetin alfa.
    Read Article

    Quick Quiz: Chronic Myeloid Leukemia

    Quick Quiz: Chronic Myeloid Leukemia

    Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is a malignancy that originates in blood-forming cells (called myeloid cells) found in bone marrow. How much do you know about chronic myeloid leukemia?

    Start the Quiz
      • Murray Aitken, MBA
      • Executive Director
      • IQVIA Institute
      • Brian Ansay
      • President, Specialty Physician GPOs
      • AmerisourceBergen
      • Roy Baynes, MD, PhD
      • Head, Global Clinical Development, Chief Medical Officer
      • Merck Research Laboratories
      • Al Benson, MD, FACP, FASCO
      • Professor or Medicine, Lurie Cancer Center
      • Northwestern University
      • Past Chair
      • NCCN
      • Mick Besse, MBA
      • President
      • Besse Medical, AmerisourceBergen
      • Linda Bosserman, MD, FASCO, FACP
      • Assistant Clinical Professor
      • City of Hope Medical Center
      • Roger Brito, DO
      • Division Head-Enterprise Oncology
      • CVS Health
      • Howard “Skip” Burris, III, MD, FACP, FASCO
      • President & Chief Medical Officer
      • Sarah Cannon
      • Rob Butcher
      • CEO
      • Swim Across America
      • Karen van Caulil, PhD
      • President & CEO
      • Florida Alliance for Healthcare Value
      • Kevan Corbett
      • VP/GM, GPO Services & Business Solutions
      • McKesson
      • David DeRemer, PharmD, BCOP, FCCP, FHOPA
      • Clinical Associate Professor & Assistant Director
      • Experimental Therapeutics
      • University of Florida Health Cancer Center
      • Michael Diaz, MD
      • Assistant Managing Physician & Vice President
      • Florida Cancer Specialists
      • Gabriela Dieguez, FSA, MAAA
      • Principal & Consulting Actuary
      • Milliman
      • Christian Downs, MHA, JD
      • Executive Director
      • Association of Community Cancer Centers
      • Andrea Dwyer, BS
      • Vice Chair
      • Colorado Cancer Coalition
      • Co-Chair, National Navigation Roundtable
      • American Cancer Society
      • Craig Eagle, MD
      • VP, Medical Affairs Oncology
      • Genentech
      • Bruce Feinberg, DO
      • Vice President and Chief Medical Officer
      • Cardinal Health Specialty Solutions
      • John Fox, MD
      • Associate Vice President of Medical Affairs
      • Priority Health
      • Elizabeth Franklin, PhD, MSW
      • Executive Director
      • Cancer Policy Institute
      • Co-Chair, Policy & Advocacy Committee
      • Academy of Oncology Nurse & Patient Navigators
      • Scott Freeswick, MS, PharmD
      • Vice President & CPO
      • Memorial Sloan Kettering Cancer Center
      • Marianne Gandee
      • Senior Director, Team Lead
      • Advocacy and Professional Relations
      • Pfizer Oncology
      • Michael Ganio, PharmD
      • Senior Director, Pharmacy Practice and Quality
      • ASHP
      • Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
      • Program Director
      • Academy of Oncology Nurse & Patient Navigators
      • Gerry Gleeson, MBA
      • VP & US Head of Market Access
      • Sandoz Inc.
      • Brian Gockerman, MBA
      • Managing Director
      • Unlimited Systems
      • Rena Goins
      • Executive Director
      • Global Trade, GPO & Distribution
      • Regeneron Healthcare Solutions, Inc.
      • Bob Gold
      • Chief Behavioral Technologist and CEO
      • GoMo Health
      • Patricia Goldsmith
      • CEO
      • CancerCare
      • Lucio Gordan, MD
      • President
      • Florida Cancer Specialists
      • Niesha Griffith, RPh, MS, FASHP
      • Chief Pharmacy Officer (Interim)
      • Naomi Gutierrez
      • Vice President
      • Account Management
      • McKesson
      • Mark Hagler, MBA
      • Senior Vice President Business Unit Head
      • US Oncology
      • Sun Pharma
      • Murray Harber
      • Executive Director
      • Mississippi Business Group on Health
      • Lisa Harrison, RPh
      • President
      • Oncology Supply, AmerisourceBergen
      • Arthur Hirt
      • Vice President
      • Oncology Commercial Operations, US Market
      • Merck
      • Ann Mond Johnson
      • CEO
      • ATA
      • Michael Joyner, MD
      • Professor
      • Mayo Clinic
      • Deborah Kamin, RN, PhD
      • Vice President
      • Policy and Advocacy
      • American Society of Clinical Oncology
      • Duane Kembel
      • National Vice President
      • Physician Office Sales
      • Cardinal Health
      • Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN
      • Scientific & Clinical Affairs Liaison
      • Oncology Nursing Society
      • Karen Keown, RN
      • Co-Founder
      • Vida Healthcare
      • Daniel Klein
      • President & CEO
      • Patient Access Network Foundation
      • Michael Kolodziej, MD
      • Senior Advisor
      • ADVI Health
      • Timothy Kubal, MBA, MD
      • Senior Medical Director
      • Moffitt Cancer Center, Tampa
      • Rick Lee
      • Co-Founder
      • Quality Oncology, Value Health, Healthrageous, and MeYou Health
      • Brian Leyland-Jones, MD
      • Chief Medical Officer
      • National Center for Cancer Research
      • Bryan Loy, MD, MBA
      • Physician Lead, Oncology, Laboratory, and Personalized Medicine
      • Humana
      • Tom Lynch, MD
      • CEO & President
      • Fred Hutchinson Cancer Research Center
      • Barbara McAneny, MD, MACP, FASCO
      • CEO
      • New Mexico Oncology Hematology Consultants
      • Chris Marcum, PharmD
      • VP, Enterprise Pharmacy
      • Cancer Treatment Centers of America
      • Maurie Markman, MD
      • President, Medicine & Science
      • Cancer Treatment Centers of America
      • Ali McBride, PharmD, MBA
      • Clinical Coordinator
      • University of Arizona Cancer Center
      • Stacey McCullough, PharmD
      • SVP, Pharmacy
      • Tennessee Oncology, LLC
      • Brenda Nevidjon, MSN, RN, FAAN
      • CEO
      • Oncology Nursing Society
      • Lee Newcomer, MD
      • Former SVP
      • Oncology and Genetics
      • UnitedHealth Group
      • Principal
      • Lee N. Newcomer Consulting
      • Amy Niles
      • Executive Vice President
      • Patient Access Network Foundation
      • John O’Brien, PharmD, MPH
      • Former Senior Advisor to Secretary of US Department Health & Human Services
      • Kevin O’Hayer, MD, PhD
      • Senior Director
      • Immuno-Oncology
      • Incyte Corporation
      • Ted Okon, MBA
      • Executive Director
      • Community Oncology Alliance
      • Kashyap Patel, MD
      • CEO
      • Carolina Blood and Cancer Care Associates
      • Debra Patt, MD, PhD, MBA
      • Executive Vice President
      • Policy and Strategic Initiatives
      • Texas Oncology
      • Jeff Patton, MD
      • CEO
      • Tennessee Oncology
      • Pamela Pelizzari, MPH
      • Principal and Senior Healthcare Consultant
      • Milliman
      • Steven Peskin, MD, MBA, FACP
      • Executive Medical Director of Population Health and Transformation
      • Horizon BCBS
      • Bruce Pyenson, FSA, MAAA
      • Principal & Consulting Actuary
      • Milliman
      • Chevon Rariy, MD
      • Director, Telehealth
      • Cancer Treatment Centers of America
      • Julie Saba, MD, PhD
      • Professor of Pediatrics
      • UCSF
      • Richard Schilsky, MD, FACP, FSCT, FASCO
      • Executive Vice President and Chief Medical Officer
      • ASCO
      • Julian Schink, MD
      • Chief Medical Officer
      • Cancer Treatment Centers of America
      • Patrick Schmidt
      • CEO
      • FFF Enterprises
      • Bhavesh Shah, RPh, BCOP
      • Director of Specialty and Hematology/Oncology Pharmacy
      • Boston Medical Center
      • Nirav Shah, MBA
      • Head of Revenue Cycle Operations, Flatiron Health
      • Parag Shah
      • President, Practice Solutions
      • Integra Connect
      • Michael Sherman, MD, MBA, MS, SVP
      • Chief Medical Officer
      • Harvard Pilgrim Healthcare
      • Lillie Shockney, RN, BS, MAS, HON-ONN-CG
      • University Distinguished Service Professor of Breast Cancer
      • Professor of Surgery
      • Johns Hopkins University School of Medicine
      • Mark Sloan, MD
      • Associate Professor of Medicine
      • Boston University School of Medicine
      • Jayson Slotnik, JD, MPH
      • Managing Partner
      • Health Policy Strategies
      • Art Taft
      • Managing Director
      • Medworks
      • Amy Valley, PharmD
      • Vice President
      • Clinical Strategy and Technology Solutions
      • Cardinal Health Specialty Solutions
      • Randy Vogenberg, PhD
      • Board Chair
      • Employer-Provider Interface Council [EPIC] of the HQF
      • Principal
      • Institute for Integrated Healthcare
      • Sally Werner, RN, BSN, MSHA
      • Executive Director
      • Institute for Excellence in Psychosocial Care
      • Cancer Support Community
      • Bruce Wilson
      • Head
      • Access Strategy
      • US Oncology
      • AstraZeneca
      • Jedd Wolchok, MD, PhD, FASCO
      • Chief
      • Immuno-Oncology
      • Memorial Sloan Kettering Cancer Center
      • Bryon Wornson
      • VP, Oncology Patient and Health Impact Lead
      • Pfizer
      • Burt Zweigenhaft, PhD, D.Litt
      • Founder & Co-Chair
      • AVBCC

    Latest Videos

    We Want to Know

    *Is access to care an obstacle for patients today?


    SPAM Check, leave blank

    Stay In The Know

    Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

    Subscribe
    © Amplity Health. All Rights Reserved. Privacy Policy.